Aristea Therapeutics
closedA clinical-stage drug development company developing novel therapies to treat serious inflammatory diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD344—515m (Dealroom.co estimates Jul 2021.)
San Diego California (HQ)
Authorizing premium user...